ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Shareholder Equity 2013–2025
ImmunityBio, Inc. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- ImmunityBio, Inc. shareholder equity as of December 31, 2025: -500.5M, a 2.32% increase year-over-year.
- ImmunityBio, Inc. shareholder equity for 2025 were -500.5M, a 2.32% increase from 2024.
- ImmunityBio, Inc. shareholder equity for 2024 were -489.1M, a 16.68% decrease from 2023.
- ImmunityBio, Inc. shareholder equity for 2023 were -587.0M, a 31.22% increase from 2022.
- ImmunityBio, Inc. shareholder equity for 2022 were -447.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ImmunityBio, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-500 |
| 2024 | $-489 |
| 2023 | $-587 |
| 2022 | $-447 |
| 2021 | $-242 |
| 2020 | $-120 |
| 2019 | $121 |
| 2018 | $146 |
| 2017 | $219 |
| 2016 | $293 |
| 2015 | $356 |
| 2014 | $58 |
ImmunityBio, Inc. Shareholder Equity — FAQ
ImmunityBio, Inc. (IBRX) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IBRX's shareholder equity history?
The chart and table above show ImmunityBio, Inc.'s shareholder equity by year and by quarter, including the growth rate.